APO Research
Talk to an analyst

APO RESEARCH · REPORT

Platinum based Cancer Drug

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

Selected research

Market Structure

Global Platinum based Cancer Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025196 pages

Choose your research edition.

Industry ResearchPlatinum based Cancer Drug Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Platinum based Cancer Drug Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Platinum based Cancer Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Platinum based Cancer Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Platinum based Cancer Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin is about 71%.

Platinum based cancer drug is widely used for colorectal cancer, ovarian cancer, lung cancer and other cancer. The most proportion of platinum based cancer drug is for colorectal cancer, and the proportion is about 62%.

Read the full market overview

Asia-Pacific is the largest market, with a sales market share nearly 53%. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.

Market competition is intense. Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical and Teva, etc. are the leaders of the industry, with about 42% market shares.

This report provides an overview of the global Platinum based Cancer Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Platinum based Cancer Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Platinum based Cancer Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Platinum based Cancer Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Platinum based Cancer Drug Segment by Company

Sanofi

Hengrui Medicine

ASK Pharma

Yi Bai Pharmaceutical

Qilu Pharmaceutical

Teva

Pfizer

Dr Reddy's Laboratories

Mylan

Sun Pharma

Novartis

Debiopharm

Accord Healthcare

SK Chemicals

Platinum based Cancer Drug Segment by Type

Cisplatin

Oxaliplatin

Carboplatin

Others

Platinum based Cancer Drug Segment by Application

Colorectal Cancer

Ovarian Cancer

Lung Cancer

Others

Platinum based Cancer Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Platinum based Cancer Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Platinum based Cancer Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Platinum based Cancer Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Platinum based Cancer Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Platinum based Cancer Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Platinum based Cancer Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Platinum based Cancer Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Platinum based Cancer Drug Industry Trends Table 2. Platinum based Cancer Drug Industry Drivers Table 3. Platinum based Cancer Drug Industry Opportunities and Challenges Table 4. Platinum based Cancer Drug Industry Restraints Table 5. Global Platinum based Cancer Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Platinum based Cancer Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Platinum based Cancer Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Platinum based Cancer Drug Sales Market Share by Manufacturers Table 9. Global Platinum based Cancer Drug Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Platinum based Cancer Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Platinum based Cancer Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Platinum based Cancer Drug Manufacturers, Product Type & Application Table 13. Global Platinum based Cancer Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Platinum based Cancer Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Cisplatin Table 17. Major Manufacturers of Oxaliplatin Table 18. Major Manufacturers of Carboplatin Table 19. Major Manufacturers of Others Table 20. Global Platinum based Cancer Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Platinum based Cancer Drug Sales by Type (2021-2026) & (K Units) Table 22. Global Platinum based Cancer Drug Sales by Type (2027-2032) & (K Units) Table 23. Global Platinum based Cancer Drug Sales Market Share by Type (2021-2026) Table 24. Global Platinum based Cancer Drug Sales Market Share by Type (2027-2032) Table 25. Global Platinum based Cancer Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Platinum based Cancer Drug Revenue by Type (2021-2026) & (K Units) Table 27. Global Platinum based Cancer Drug Revenue by Type (2027-2032) & (K Units) Table 28. Global Platinum based Cancer Drug Revenue Market Share by Type (2021-2026) Table 29. Global Platinum based Cancer Drug Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Colorectal Cancer Table 31. Major Manufacturers of Ovarian Cancer Table 32. Major Manufacturers of Lung Cancer Table 33. Major Manufacturers of Others Table 34. Global Platinum based Cancer Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Platinum based Cancer Drug Sales by Application (2021-2026) & (K Units) Table 36. Global Platinum based Cancer Drug Sales by Application (2027-2032) & (K Units) Table 37. Global Platinum based Cancer Drug Sales Market Share by Application (2021-2026) Table 38. Global Platinum based Cancer Drug Sales Market Share by Application (2027-2032) Table 39. Global Platinum based Cancer Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Platinum based Cancer Drug Revenue by Application (2021-2026) & (K Units) Table 41. Global Platinum based Cancer Drug Revenue by Application (2027-2032) & (K Units) Table 42. Global Platinum based Cancer Drug Revenue Market Share by Application (2021-2026) Table 43. Global Platinum based Cancer Drug Revenue Market Share by Application (2027-2032) Table 44. Global Platinum based Cancer Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Platinum based Cancer Drug Sales by Region (2021-2026) & (K Units) Table 46. Global Platinum based Cancer Drug Sales Market Share by Region (2021-2026) Table 47. Global Platinum based Cancer Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Platinum based Cancer Drug Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Platinum based Cancer Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Platinum based Cancer Drug Sales by Country (2021-2026) & (K Units) Table 51. North America Platinum based Cancer Drug Sales by Country (2027-2032) & (K Units) Table 52. Europe Platinum based Cancer Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Platinum based Cancer Drug Sales by Country (2021-2026) & (K Units) Table 54. Europe Platinum based Cancer Drug Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Platinum based Cancer Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Platinum based Cancer Drug Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Platinum based Cancer Drug Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Platinum based Cancer Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Platinum based Cancer Drug Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Platinum based Cancer Drug Sales by Country (2027-2032) & (K Units) Table 61. Global Platinum based Cancer Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Platinum based Cancer Drug Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Platinum based Cancer Drug Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Platinum based Cancer Drug Revenue Market Share by Region (2021-2026) Table 65. Global Platinum based Cancer Drug Revenue Market Share by Region (2027-2032) Table 66. Sanofi Company Information Table 67. Sanofi Business Overview Table 68. Sanofi Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Sanofi Platinum based Cancer Drug Product Portfolio Table 70. Sanofi Recent Development Table 71. Hengrui Medicine Company Information Table 72. Hengrui Medicine Business Overview Table 73. Hengrui Medicine Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Hengrui Medicine Platinum based Cancer Drug Product Portfolio Table 75. Hengrui Medicine Recent Development Table 76. ASK Pharma Company Information Table 77. ASK Pharma Business Overview Table 78. ASK Pharma Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. ASK Pharma Platinum based Cancer Drug Product Portfolio Table 80. ASK Pharma Recent Development Table 81. Yi Bai Pharmaceutical Company Information Table 82. Yi Bai Pharmaceutical Business Overview Table 83. Yi Bai Pharmaceutical Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Yi Bai Pharmaceutical Platinum based Cancer Drug Product Portfolio Table 85. Yi Bai Pharmaceutical Recent Development Table 86. Qilu Pharmaceutical Company Information Table 87. Qilu Pharmaceutical Business Overview Table 88. Qilu Pharmaceutical Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Qilu Pharmaceutical Platinum based Cancer Drug Product Portfolio Table 90. Qilu Pharmaceutical Recent Development Table 91. Teva Company Information Table 92. Teva Business Overview Table 93. Teva Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Teva Platinum based Cancer Drug Product Portfolio Table 95. Teva Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Pfizer Platinum based Cancer Drug Product Portfolio Table 100. Pfizer Recent Development Table 101. Dr Reddy's Laboratories Company Information Table 102. Dr Reddy's Laboratories Business Overview Table 103. Dr Reddy's Laboratories Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Dr Reddy's Laboratories Platinum based Cancer Drug Product Portfolio Table 105. Dr Reddy's Laboratories Recent Development Table 106. Mylan Company Information Table 107. Mylan Business Overview Table 108. Mylan Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Mylan Platinum based Cancer Drug Product Portfolio Table 110. Mylan Recent Development Table 111. Sun Pharma Company Information Table 112. Sun Pharma Business Overview Table 113. Sun Pharma Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Sun Pharma Platinum based Cancer Drug Product Portfolio Table 115. Sun Pharma Recent Development Table 116. Novartis Company Information Table 117. Novartis Business Overview Table 118. Novartis Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Novartis Platinum based Cancer Drug Product Portfolio Table 120. Novartis Recent Development Table 121. Debiopharm Company Information Table 122. Debiopharm Business Overview Table 123. Debiopharm Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Debiopharm Platinum based Cancer Drug Product Portfolio Table 125. Debiopharm Recent Development Table 126. Accord Healthcare Company Information Table 127. Accord Healthcare Business Overview Table 128. Accord Healthcare Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Accord Healthcare Platinum based Cancer Drug Product Portfolio Table 130. Accord Healthcare Recent Development Table 131. SK Chemicals Company Information Table 132. SK Chemicals Business Overview Table 133. SK Chemicals Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. SK Chemicals Platinum based Cancer Drug Product Portfolio Table 135. SK Chemicals Recent Development Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Platinum based Cancer Drug Distributors List Table 139. Platinum based Cancer Drug Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Platinum based Cancer Drug Product Image Figure 2. Global Platinum based Cancer Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Platinum based Cancer Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Platinum based Cancer Drug Sales (2021-2032) & (K Units) Figure 5. Global Platinum based Cancer Drug Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Platinum based Cancer Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Cisplatin Image Figure 9. Oxaliplatin Image Figure 10. Carboplatin Image Figure 11. Others Image Figure 12. Global Platinum based Cancer Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Platinum based Cancer Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Platinum based Cancer Drug Sales Market Share by Type (2021-2032) Figure 15. Global Platinum based Cancer Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Platinum based Cancer Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Platinum based Cancer Drug Revenue Market Share by Type (2021-2032) Figure 18. Colorectal Cancer Image Figure 19. Ovarian Cancer Image Figure 20. Lung Cancer Image Figure 21. Others Image Figure 22. Global Platinum based Cancer Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Platinum based Cancer Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Platinum based Cancer Drug Sales Market Share by Application (2021-2032) Figure 25. Global Platinum based Cancer Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Platinum based Cancer Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Platinum based Cancer Drug Revenue Market Share by Application (2021-2032) Figure 28. North America Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Platinum based Cancer Drug Sales Market Share by Country (2021-2032) Figure 30. U.S. Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Platinum based Cancer Drug Sales Market Share by Country (2021-2032) Figure 35. Germany Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Platinum based Cancer Drug Sales Market Share by Country (2021-2032) Figure 42. China Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Platinum based Cancer Drug Sales Market Share by Country (2021-2032) Figure 50. Brazil Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Platinum based Cancer Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Platinum based Cancer Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Platinum based Cancer Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Figure 61. North America Platinum based Cancer Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Figure 63. Europe Platinum based Cancer Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Platinum based Cancer Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Platinum based Cancer Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Platinum based Cancer Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Platinum based Cancer Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Cisplatin
  • Oxaliplatin
  • Carboplatin
  • Others
Applications
  • Colorectal Cancer
  • Ovarian Cancer
  • Lung Cancer
  • Others
Companies covered
  • Sanofi
  • Hengrui Medicine
  • ASK Pharma
  • Yi Bai Pharmaceutical
  • Qilu Pharmaceutical
  • Teva
  • Pfizer
  • Dr Reddy's Laboratories
  • Mylan
  • Sun Pharma
  • Novartis
  • Debiopharm
  • Accord Healthcare
  • SK Chemicals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Platinum based Cancer Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Platinum based Cancer Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Platinum based Cancer Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Platinum based Cancer Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Platinum based Cancer Drug Market Dynamics
  1. 2.1 Platinum based Cancer Drug Industry Trends
  2. 2.2 Platinum based Cancer Drug Industry Drivers
  3. 2.3 Platinum based Cancer Drug Industry Opportunities and Challenges
  4. 2.4 Platinum based Cancer Drug Industry Restraints
3 Platinum based Cancer Drug Market by Manufacturers
  1. 3.1 Global Platinum based Cancer Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Platinum based Cancer Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Platinum based Cancer Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Platinum based Cancer Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Platinum based Cancer Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Platinum based Cancer Drug Manufacturers, Product Type & Application
  7. 3.7 Global Platinum based Cancer Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Platinum based Cancer Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Platinum based Cancer Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Platinum based Cancer Drug Tier 1, Tier 2, and Tier 3
4 Platinum based Cancer Drug Market by Type
  1. 4.1 Platinum based Cancer Drug Type Introduction
  2. 4.1.1 Cisplatin
  3. 4.1.2 Oxaliplatin
  4. 4.1.3 Carboplatin
  5. 4.1.4 Others
  6. 4.2 Global Platinum based Cancer Drug Sales by Type
  7. 4.2.1 Global Platinum based Cancer Drug Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Platinum based Cancer Drug Sales by Type (2021-2032)
  9. 4.2.3 Global Platinum based Cancer Drug Sales Market Share by Type (2021-2032)
  10. 4.3 Global Platinum based Cancer Drug Revenue by Type
  11. 4.3.1 Global Platinum based Cancer Drug Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Platinum based Cancer Drug Revenue by Type (2021-2032)
  13. 4.3.3 Global Platinum based Cancer Drug Revenue Market Share by Type (2021-2032)
5 Platinum based Cancer Drug Market by Application
  1. 5.1 Platinum based Cancer Drug Application Introduction
  2. 5.1.1 Colorectal Cancer
  3. 5.1.2 Ovarian Cancer
  4. 5.1.3 Lung Cancer
  5. 5.1.4 Others
  6. 5.2 Global Platinum based Cancer Drug Sales by Application
  7. 5.2.1 Global Platinum based Cancer Drug Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Platinum based Cancer Drug Sales by Application (2021-2032)
  9. 5.2.3 Global Platinum based Cancer Drug Sales Market Share by Application (2021-2032)
  10. 5.3 Global Platinum based Cancer Drug Revenue by Application
  11. 5.3.1 Global Platinum based Cancer Drug Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Platinum based Cancer Drug Revenue by Application (2021-2032)
  13. 5.3.3 Global Platinum based Cancer Drug Revenue Market Share by Application (2021-2032)
6 Global Platinum based Cancer Drug Sales by Region
  1. 6.1 Global Platinum based Cancer Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Platinum based Cancer Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Platinum based Cancer Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Platinum based Cancer Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Platinum based Cancer Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Platinum based Cancer Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Platinum based Cancer Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Platinum based Cancer Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Platinum based Cancer Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Platinum based Cancer Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Platinum based Cancer Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Platinum based Cancer Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Platinum based Cancer Drug Revenue by Region
  1. 7.1 Global Platinum based Cancer Drug Revenue by Region
  2. 7.1.1 Global Platinum based Cancer Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Platinum based Cancer Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Platinum based Cancer Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Platinum based Cancer Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Platinum based Cancer Drug Revenue (2021-2032)
  8. 7.2.2 North America Platinum based Cancer Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Platinum based Cancer Drug Revenue (2021-2032)
  11. 7.3.2 Europe Platinum based Cancer Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Platinum based Cancer Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Platinum based Cancer Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Platinum based Cancer Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Platinum based Cancer Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Platinum based Cancer Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Platinum based Cancer Drug Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Hengrui Medicine
  8. 8.2.1 Hengrui Medicine Company Information
  9. 8.2.2 Hengrui Medicine Business Overview
  10. 8.2.3 Hengrui Medicine Platinum based Cancer Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hengrui Medicine Platinum based Cancer Drug Product Portfolio
  12. 8.2.5 Hengrui Medicine Recent Developments
  13. 8.3 ASK Pharma
  14. 8.3.1 ASK Pharma Company Information
  15. 8.3.2 ASK Pharma Business Overview
  16. 8.3.3 ASK Pharma Platinum based Cancer Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ASK Pharma Platinum based Cancer Drug Product Portfolio
  18. 8.3.5 ASK Pharma Recent Developments
  19. 8.4 Yi Bai Pharmaceutical
  20. 8.4.1 Yi Bai Pharmaceutical Company Information
  21. 8.4.2 Yi Bai Pharmaceutical Business Overview
  22. 8.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Yi Bai Pharmaceutical Platinum based Cancer Drug Product Portfolio
  24. 8.4.5 Yi Bai Pharmaceutical Recent Developments
  25. 8.5 Qilu Pharmaceutical
  26. 8.5.1 Qilu Pharmaceutical Company Information
  27. 8.5.2 Qilu Pharmaceutical Business Overview
  28. 8.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Qilu Pharmaceutical Platinum based Cancer Drug Product Portfolio
  30. 8.5.5 Qilu Pharmaceutical Recent Developments
  31. 8.6 Teva
  32. 8.6.1 Teva Company Information
  33. 8.6.2 Teva Business Overview
  34. 8.6.3 Teva Platinum based Cancer Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Teva Platinum based Cancer Drug Product Portfolio
  36. 8.6.5 Teva Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Platinum based Cancer Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Platinum based Cancer Drug Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Dr Reddy's Laboratories
  44. 8.8.1 Dr Reddy's Laboratories Company Information
  45. 8.8.2 Dr Reddy's Laboratories Business Overview
  46. 8.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Dr Reddy's Laboratories Platinum based Cancer Drug Product Portfolio
  48. 8.8.5 Dr Reddy's Laboratories Recent Developments
  49. 8.9 Mylan
  50. 8.9.1 Mylan Company Information
  51. 8.9.2 Mylan Business Overview
  52. 8.9.3 Mylan Platinum based Cancer Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mylan Platinum based Cancer Drug Product Portfolio
  54. 8.9.5 Mylan Recent Developments
  55. 8.10 Sun Pharma
  56. 8.10.1 Sun Pharma Company Information
  57. 8.10.2 Sun Pharma Business Overview
  58. 8.10.3 Sun Pharma Platinum based Cancer Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sun Pharma Platinum based Cancer Drug Product Portfolio
  60. 8.10.5 Sun Pharma Recent Developments
  61. 8.11 Novartis
  62. 8.11.1 Novartis Company Information
  63. 8.11.2 Novartis Business Overview
  64. 8.11.3 Novartis Platinum based Cancer Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Novartis Platinum based Cancer Drug Product Portfolio
  66. 8.11.5 Novartis Recent Developments
  67. 8.12 Debiopharm
  68. 8.12.1 Debiopharm Company Information
  69. 8.12.2 Debiopharm Business Overview
  70. 8.12.3 Debiopharm Platinum based Cancer Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Debiopharm Platinum based Cancer Drug Product Portfolio
  72. 8.12.5 Debiopharm Recent Developments
  73. 8.13 Accord Healthcare
  74. 8.13.1 Accord Healthcare Company Information
  75. 8.13.2 Accord Healthcare Business Overview
  76. 8.13.3 Accord Healthcare Platinum based Cancer Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Accord Healthcare Platinum based Cancer Drug Product Portfolio
  78. 8.13.5 Accord Healthcare Recent Developments
  79. 8.14 SK Chemicals
  80. 8.14.1 SK Chemicals Company Information
  81. 8.14.2 SK Chemicals Business Overview
  82. 8.14.3 SK Chemicals Platinum based Cancer Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 SK Chemicals Platinum based Cancer Drug Product Portfolio
  84. 8.14.5 SK Chemicals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Platinum based Cancer Drug Value Chain Analysis
  2. 9.1.1 Platinum based Cancer Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Platinum based Cancer Drug Production Mode & Process
  6. 9.2 Platinum based Cancer Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Platinum based Cancer Drug Distributors
  9. 9.2.3 Platinum based Cancer Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst